Brief: Seegene Inc and Werfen Partner To Collaborate On Onesystem Business To Develop Syndromic QPCR Assays
14/06/2023 12:07
June 14 (Reuters) - Seegene Inc 096530.KQ :
* SEEGENE INC - CO, WERFEN PARTNER TO COLLABORATE ON
ONESYSTEM
BUSINESS TO DEVELOP SYNDROMIC QPCR ASSAYS
Source text for Eikon: ID:nPn6B8bHda
Further company coverage: 096530.KQ
Recent news on Seegene
See all newsBrief: Seegene To Cancel 174 Billion Won Worth Of Own Shares
Brief: Seegene Q4 Operating Profit 7 Billion Won, Swings To Profit From Year Earlier
Brief: Seegene Establishes French Subsidiary To Expand European Footprint
Brief: Seegene Q2 Operating Profit 3 Billion Won, Swings To Profit From Year Earlier
Brief: Seegene Q1 Operating Profit 14.8 Billion Won, Swings To Profit From Year Earlier